Clean Slate Clinic Raises $4.3M in Convertible Note and Debt Financing

Why It Matters

By scaling a proven, reimbursable home detox solution, Clean Slate could dramatically increase treatment access and reduce long‑term healthcare costs in Australia and abroad.

Key Takeaways

• Raised $2.8M note and $1.5M debt, total $4.3M AUD (~$2.8M USD).
• Serves over 3,000 clients detoxing from alcohol, stimulants, cannabis.
• Targets UK expansion and broader markets with $10M Series A goal.
• Secured reimbursement from most Australian private health insurers.
• Clinical home detox fills gap in Australian health system.

Pulse Analysis

The demand for accessible substance‑use treatment has surged as clinicians recognize that traditional inpatient detox is often inaccessible, costly, or stigmatized. Virtual platforms like Clean Slate Clinic leverage telehealth and remote monitoring to deliver clinician‑led detox at home, a model that aligns with post‑pandemic consumer preferences for digital health. By integrating evidence‑based protocols with real‑time data, the service can safely manage withdrawal symptoms while reducing the need for hospital beds, a critical advantage in health systems strained by chronic disease burdens.

Clean Slate’s recent $4.3 million AUD raise, led by impact investor Giant Leap, underscores growing investor confidence in scalable, socially responsible health tech. The convertible note and debt facility not only provide runway for product refinement but also signal market validation, especially after the company secured reimbursement from the majority of Australia’s private insurers. This financial backing paves the way for a $10 million AUD Series A, earmarked for a strategic push into the United Kingdom—a market with comparable insurance structures and a sizable unmet need for home‑based detox services.

If Clean Slate successfully replicates its Australian model abroad, the ripple effects could reshape how health systems address addiction. Wider adoption would likely lower overall treatment costs, improve early‑intervention rates, and generate data that informs policy on substance‑use disorders. Moreover, the social‑enterprise framework—balancing profit with patient outcomes—offers a template for future health‑tech ventures seeking both impact and sustainable growth.

Deal Summary

Australian virtual alcohol detox platform Clean Slate Clinic completed a $4.3M capital raise, including a $2.8M convertible note from impact investor Giant Leap and Scale Investors, and a $1.5M debt facility from Australian Medical Angels. The funding will support its growth ahead of a planned $10M Series A and expansion into the UK and other markets.